D. Bets

1.9k total citations · 1 hit paper
9 papers, 1.4k citations indexed

About

D. Bets is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pharmacology. According to data from OpenAlex, D. Bets has authored 9 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in D. Bets's work include Diabetes Treatment and Management (6 papers), Metabolism, Diabetes, and Cancer (4 papers) and Pharmacology and Obesity Treatment (3 papers). D. Bets is often cited by papers focused on Diabetes Treatment and Management (6 papers), Metabolism, Diabetes, and Cancer (4 papers) and Pharmacology and Obesity Treatment (3 papers). D. Bets collaborates with scholars based in Netherlands, Belgium and United States. D. Bets's co-authors include M. G. Wulffelé, Coen D.A. Stehouwer, Adriaan Kooy, A. J. M. Donker, J. de Jager, Philippe Lehert, J. van der Kolk, J. Verbürg, P. Lehert and Casper G. Schalkwijk and has published in prestigious journals such as Diabetes Care, Journal of Internal Medicine and Diabetic Medicine.

In The Last Decade

D. Bets

8 papers receiving 1.3k citations

Hit Papers

Long term treatment with metformin in patients with type ... 2010 2026 2015 2020 2010 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Bets Netherlands 7 767 544 346 267 267 9 1.4k
M. G. Wulffelé Netherlands 9 964 1.3× 689 1.3× 352 1.0× 336 1.3× 317 1.2× 11 1.7k
J. de Jager Netherlands 6 630 0.8× 460 0.8× 229 0.7× 216 0.8× 216 0.8× 10 1.2k
Patrick Sheridan Canada 12 1.0k 1.3× 628 1.2× 275 0.8× 303 1.1× 261 1.0× 13 1.8k
Gary Ko Hong Kong 23 559 0.7× 390 0.7× 144 0.4× 265 1.0× 140 0.5× 51 1.6k
Eric Grossman United States 9 321 0.4× 559 1.0× 131 0.4× 235 0.9× 115 0.4× 16 1.5k
R.J. Heine Netherlands 22 920 1.2× 363 0.7× 66 0.2× 264 1.0× 310 1.2× 40 1.6k
Dalila B. Corry United States 16 373 0.5× 297 0.5× 100 0.3× 335 1.3× 142 0.5× 30 1.4k
Marco Righetti Italy 14 425 0.6× 269 0.5× 173 0.5× 119 0.4× 178 0.7× 34 1.1k
Steffi Kopprasch Germany 18 233 0.3× 254 0.5× 96 0.3× 237 0.9× 145 0.5× 56 1.1k
Mirjam Schuchardt Germany 24 298 0.4× 593 1.1× 89 0.3× 355 1.3× 240 0.9× 54 2.1k

Countries citing papers authored by D. Bets

Since Specialization
Citations

This map shows the geographic impact of D. Bets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Bets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Bets more than expected).

Fields of papers citing papers by D. Bets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Bets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Bets. The network helps show where D. Bets may publish in the future.

Co-authorship network of co-authors of D. Bets

This figure shows the co-authorship network connecting the top 25 collaborators of D. Bets. A scholar is included among the top collaborators of D. Bets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Bets. D. Bets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jager, J. de, Adriaan Kooy, Casper G. Schalkwijk, et al.. (2013). Long‐term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial. Journal of Internal Medicine. 275(1). 59–70. 100 indexed citations
2.
Jager, J. de, Adriaan Kooy, Philippe Lehert, et al.. (2010). Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 340(may19 4). c2181–c2181. 463 indexed citations breakdown →
3.
Kooy, Adriaan, J. de Jager, Philippe Lehert, et al.. (2009). Meerwaarde van toevoeging metformine aan insulinetherapie bij type 2-diabetes. Gunstiger gewicht met minder macrovasculaire complicaties. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 153. 1 indexed citations
4.
Kooy, Adriaan, J. de Jager, Philippe Lehert, et al.. (2009). Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus. Archives of Internal Medicine. 169(6). 616–616. 305 indexed citations
5.
Wulffelé, M. G., Adriaan Kooy, P. Lehert, et al.. (2005). Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin?. Diabetic Medicine. 22(7). 907–913. 22 indexed citations
6.
Jager, J. de, Adriaan Kooy, P. Lehert, et al.. (2004). Effects of short‐term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo‐controlled trial. Journal of Internal Medicine. 257(1). 100–109. 179 indexed citations
7.
Wulffelé, M. G., Adriaan Kooy, P. Lehert, et al.. (2003). Effects of short‐term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo‐controlled trial. Journal of Internal Medicine. 254(5). 455–463. 188 indexed citations
8.
Wulffelé, M. G., Adriaan Kooy, Philippe Lehert, et al.. (2002). Discontinuation of metformin in type 2 diabetes patients treated with insulin.. PubMed. 60(6). 249–52. 3 indexed citations
9.
Wulffelé, M. G., Adriaan Kooy, Philippe Lehert, et al.. (2002). Combination of Insulin and Metformin in the Treatment of Type 2 Diabetes. Diabetes Care. 25(12). 2133–2140. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026